MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway

International Journal of Molecular Medicine

Volumn 33, Issue 4, 2014, Pages 950-956

  Zhou, Jian ^a   Song, Shiduo ^a   He, Songbing ^a,b   Zhu, Xinguo ^a   Zhang, Y I ^a   Yi, Bin ^a   Zhang, Bing ^a   Qin, Gongzhao ^c   Li, Dechun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

3 phosphoinositide dependent protein kinase 1; Akt; MicroRNA 375; Pancreatic carcinoma

Indexed keywords

MICRORNA 375; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84899510151     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1638     Document Type: Article

References (28)

1. Chen X, Ma S and Zhang Z: Analysis of clinical characteristics of pancreatic carcinoma in northern China. Pancreas 39: 1116-1118, 2010.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
4. Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet 378: 607-620, 2011.
5. Ruan K, Fang X and Ouyang G: microRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285: 116-126, 2009.
6. Hrašovec S and Glavač D: microRNAs as Novel Biomarkers in Colorectal Cancer. Front Genet 3: 180, 2012.
7. Chen PS, Su JL and Hung MC: Dysregulation of microRNAs in cancer. J Biomed Sci 19: 90, 2012.
8. Liu H: microRNAs in breast cancer initiation and progression. Cell Mol Life Sci 69: 3587-3599, 2012.
9. Poy MN, Eliasson L, Krutzfeldt J, et al: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230, 2004. (Pubitemid 39545853)
10. Zhang WH, Gui JH, Wang CZ, et al: The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma. Oncol Res 20: 139-147, 2012.
11. Chang Y, Yan W, He X, et al: miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 143: 177-187.8, 2012.
12. Dai X, Chiang Y, Wang Z, et al: Expression levels of microRNA-375 in colorectal carcinoma. Mol Med Rep 5: 1299-1304, 2012.
13. Raimondi C and Falasca M: Targeting PDK1 in cancer. Curr Med Chem 18: 2763-2769, 2011.
14. Westmoreland JJ, Wang Q, Bouzaffour M, Baker SJ and Sosa-Pineda B: Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells. Dev Biol 334: 285-298, 2009.
15. Nikitina EG, Urazova LN and Stegny VN: microRNAs and human cancer. Exp Oncol 34: 2-8, 2012.
16. He XX, Chang Y, Meng FY, et al: microRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 31: 3357-3369, 2012.
17. Tsukamoto Y, Nakada C, Noguchi T, et al: microRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349, 2010.
18. Shen Y, Wang P, Li Y, et al: miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. Br J Cancer 109: 92-99, 2013.
19. Garzon R, Calin GA and Croce CM: microRNAs in Cancer. Annu Rev Med 60: 167-179, 2009.
20. Liu AM, Poon RT and Luk JM: microRNA-375 targets Hipposignaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 394: 623-627, 2010.
21. Li X, Lin R and Li J: Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci 56: 2849-2856, 2011.
22. Ding L, Xu Y, Zhang W, et al: MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20: 784-793, 2010.
23. Nishikawa E, Osada H, Okazaki Y, et al: miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 71: 6165-6173, 2011.
24. Liu Y, Xing R, Zhang X, et al: miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells. DNA Repair (Amst) 12: 741-750, 2013.
25. Sheppard K, Kinross KM, Solomon B, Pearson RB and Phillips WA: Targeting PI3 kinase/AKT/mTOR signaling in cancer. Crit Rev Oncog 17: 69-95, 2012.
26. Dhanasekaran DN and Johnson GL: MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene 26: 3097-3099, 2007. (Pubitemid 46763009)
27. Zhang X, Yan Z, Zhang J, et al: Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol 22: 2257-2266, 2011.
28. Song J, Kim D, Chun CH and Jin EJ: microRNA-375, a new regulator of cadherin-7, suppresses the migration of chondrogenic progenitors. Cell Signal 25: 698-706, 2013.